Was formerly and is still sometimes
known by the name Manic Depressive Illness. Bipolar Disorder is
a psychiatric disorder characterized by wide moodswings from the
euphoria or agony of a manic high
to the devastation of a debilitating depression.

The treatment for Bipolar Affective
Disorder typically requires the long term use of psychiatric
medications, notably lithium carbonate, and other mood stabilizers.
One of the side effects of many
psychiatric medications is weight gain. Bipolar World addresses this
and many other topics.

PLEASE NOTE: Nothing in this web site
is intended to replace the advice of a physician or
psychiatrist. It is for information and education only. Please see
your doctor or
psychiatrist for diagnosis and treatment.

Lunesta (eszopiclone), a new non-narcotic prescription
sleep aid from Sepracor, received FDA approval on December 15, 2004.
Lunesta represents a new treatment option for those suffering from
insomnia; Lunesta not only helps people fall asleep quickly, it helps
them sleep restfully through the night, with fewer interruptions, and
wake up refreshed and ready to start the day.

The
Depression Newsletter The
Depression Newsletter
Sign up to receive three free copies of The Depression
Newlsetter, written and edited by John McMan. This is the only
newsletter of its type on the internet with current, and often
hard-hitting news and articles about Bipolar Disorder.

Psycheducation.org
Dr. Jim Phelps
For a high quality web site packed with
up to date and well referenced information about Bipolar
Disorder, don't miss Bipolar World's Ask the Doctor's own
website!

Recovery
Sources Online Recovery
Sources Online
(noun, gradual healing after sickness or injury; the act of regaining or saving something lost...) One of the largest and best resource link
pages I've seen on the internet!

The Food and
Drug Administration has approved for sale an
Indianapolis pharmaceutical company's treatment for
bipolar depression. Eli
Lilly & Co. said Symbyax should arrive in most U.S.
pharmacies in two to three weeks, the Indianapolis Star
reported. Symbyax
becomes the first FDA-approved drug to treat the
depressive phase of bipolar disorder, a hard-to-treat
mental illness with debilitating mood swings ranging
from deep depression to abnormal elation. Symbyax
is not a new chemical entity. It pairs two Lilly drugs,
Prozac and Zyprexa, in one pill.

The U.S. Food and Drug Administration (FDA) has
approved Equetro (extended-release carbamazepine capsules),
previously known as SPD417, for indicated for the treatment
of acute manic and mixed episodes associated with Bipolar I
Disorder